Have a personal or library account? Click to login
Comparative Efficacy of Microwave versus Radiofrequency Ablation in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of Randomized-Controlled Trials Cover

Comparative Efficacy of Microwave versus Radiofrequency Ablation in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of Randomized-Controlled Trials

By: Imelda Rey and  Darmadi Darmadi  
Open Access
|Jun 2024

References

  1. CHIDAMBARANATHAN-REGHUPATY S., FISHER PB., SARKAR D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1–61.
  2. HAN J., FAN Y., WANG K. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma. Medicine (Baltimore). 2020 Oct 23;99(43):e22703.
  3. POULOU LS., BOTSA E., THANOU I., ZIAKAS PD., THANOS L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol. 2015;7(8):1054–63.
  4. GLASSBERG MB., GHOSH S., CLYMER JW., QADEER RA., FERKO NC., SADEGHIRAD B., et al. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther. 2019 Aug;12:6407–38.
  5. PAGE MJ., MCKENZIE JE., BOSSUYT PM., BOUTRON I., HOFFMANN TC., MULROW CD., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3).
  6. STERNE J., SAVOVIC J., PAGE M., ELBERS R., BLENCOWE N., BOUTRON I. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366.
  7. ABDELAZIZ A., ELBAZ T., SHOUSHA HI., MAHMOUD S., IBRAHIM M., ABDELMAKSOUD A., et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience. Surg Endosc. 2014;28(12):3429–34.
  8. CHONG CCN., LEE KF., CHEUNG SYS., CHU CCM., FONG AKW., WONG J., et al. Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial). Hpb. 2020;22(8):1121–7.
  9. DI VECE F., TOMBESI P., ERMILI F., MARALDI C., SARTORI S. Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using a device to decrease back-heating effects: A prospective pilot study. Cardiovasc Intervent Radiol. 2014;37(3):723–9.
  10. KAMAL A., ELMOETY AAA., ROSTOM YAM., SHATER MS., LASHEN SA. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: A randomized controlled trial. J Gastrointest Oncol. 2019;10(3):562–71.
  11. MAHMOUD HS., ARAFAT S., ZAKY S., BAZEED SES. Microwave ablation versus Radiofrequency ablation in the management of Hepatocellular carcinoma. SVU-International J Med Sci. 2021;4(2):286–92.
  12. QIAN GJ., WANG N., SHEN Q., SHENG YH., ZHAO JQ., KUANG M., et al. Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: Experimental and clinical studies. Eur Radiol. 2012;22(9):1983–90.
  13. RADOSEVIC A., QUESADA R., SERLAVOS C., SANCHEZ J., ZUGAZAGA A., SIERRA A., et al. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial. Sci Rep. 2022;12(1):1–10.
  14. VIETTI VIOLI N., DURAN R., GUIU B., CERCUEIL JP., AUBE C., DIGKLIA A., et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3(5):317–25.
  15. SHIBATA T., IIMURO Y., YAMAMOTO Y., MAETANI Y., AMETANI F., ITOH K., et al. Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223(2):331–7.
  16. FACCIORUSSO A., ABD EL AZIZ MA., TARTAGLIA N., RAMAI D., MOHAN BP., COTSOGLOU C., et al. Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Cancers (Basel). 2020 Dec 16;12(12):3796.
  17. POGGI G. Microwave ablation of hepatocellular carcinoma. World J Hepatol. 2015;7(25):2578.
  18. IZZO F., GRANATA V., GRASSI R., FUSCO R., PALAIA R., DELRIO P., et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019 Oct 1;24(10):e990–1005.
  19. CURLEY SA. Radiofrequency Ablation of Malignant Liver Tumors. Oncologist. 2001;6(1):14–23.
  20. LEHMANN KS., POCH FGM., RIEDER C., SCHENK A., STROUX A., FRERICKS BB., et al. Minimal vascular flows cause strong heat sink effects in hepatic radiofrequency ablation ex vivo. J Hepatobiliary Pancreat Sci. 2016;23(8):508–16.
  21. TAMAI H., OKAMURA J. New next-generation microwave thermosphere ablation for small hepatocellular carcinoma. Clin Mol Hepatol. 2021;27(4):564–74.
  22. YANG W. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol. 2015;21(5):1554.
DOI: https://doi.org/10.2478/rjim-2024-0022 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 374 - 386
Submitted on: Feb 8, 2024
Published on: Jun 21, 2024
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Imelda Rey, Darmadi Darmadi, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.